Latest industry research report on: Global Intravenous Iron Drugs Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Iron
is among the vital minerals present in the human body. It is one of the
components of hemoglobin, the substance present in red blood cells that
carries oxygen throughout the body through blood, and oxygen is further
utilized by the cells to produce energy required to perform all the
required functions. Therefore, decline in the body’s supply of iron can
lead to severe problems. The balance of iron in the body primarily is a
combined result of three dynamics- intake, losses and metabolic demand.
Intravenous
(I.V.) treatment, in a broad sense, covers all the types of medications
delivered intravenously, i.e. directly into the vein, through
intravenous (I.V.) drip. Compared to the other routes of infusing
medications, the intravenous route is the fastest way to deliver fluids
and medications throughout the body. Also, this method ensures 100%
bioavailability, which means that the chemicals delivered are fully
absorbed by the body.
The
report “Global I.V. Iron Drugs Market” provides a comprehensive study
of iron product market and I.V. iron market globally. It also provides
detailed information for key regional markets of I.V iron industry. The
major trends, growth drivers as well as issues being faced by the
industry are being presented in this report. The major players in the
industry, Galenica Group, AMAG Pharmaceuticals and Allergan are being
profiled. All these companies have been profiled in the present report
highlighting their key financials and business strategies for growth.
The
key factors driving the growth of I.V. iron drugs market are growing
ageing population, growing urbanization, increase in number of dialysis
cases, rising healthcare expenditure and increasing life expectancy
rate. Some of the noteworthy trends and developments of this industry
are paradigm shift from oral iron drugs to intravenous iron drugs and
introduction of first generation drugs InFeD and Dexeferrum. However,
the expansion of the market is hindered by potential risks of I.V. iron.
Table of Contents
1. I.V. Iron Market - An Overview
1.1 Iron in Human Body: An Introduction
1.2 I.V. Iron Application Areas
1.3 I.V. Iron Applications in Nephrology
1.4 Iron Deficiency - Anemia
1.5 Iron Therapies for Anemia Treatment
2. Global Iron Product Market Analysis
2.1 Global Iron Product Market by Value
2.2 Global Iron Product Market Forecast by Value
2.3 Global Iron Product Market by Segments
3. Global I.V. Iron Drugs Market Analysis
3.1 Global I.V. Iron Drugs Market by Value
3.2 Global I.V. Iron Drugs Market Forecast by Value
3.3 Global I.V. Iron Drugs Market by Product Category
3.4 Global I.V. Iron Drugs Market Share by Product Category
3.5 Global I.V. Iron Drugs Market Share by Segments
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time
and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve
all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
No comments:
Post a Comment